Enliven Therapeutics Inc (ELVN)

May 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Sets New 52-Week Low on Insider Selling - Defense World

May 02, 2025

May 02, 2025

JPMorgan Chase & Co. Trims Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 02, 2025

May 01, 2025

Enliven (ELVN) Gains Attention as EHA Data Release Approaches | - GuruFocus

May 01, 2025

May 01, 2025

Trading (ELVN) With Integrated Risk Controls - news.stocktradersdaily.com

May 01, 2025

Apr 30, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Lowered by Legal & General Group Plc - Defense World

Apr 30, 2025

Apr 24, 2025

Enliven Therapeutics chief scientific officer sells $80,365 in stock - Investing.com Australia

Apr 24, 2025

Apr 23, 2025

Enliven Therapeutics chief scientific officer sells $80,365 in stock By Investing.com - Investing.com Nigeria

Apr 23, 2025

Apr 23, 2025

Enliven Therapeutics Inc (ELVN) shows promising results - uspostnews.com

Apr 23, 2025

Apr 22, 2025

Enliven Therapeutics: Awaiting Additional Trial Data (NASDAQ:ELVN) - Seeking Alpha

Apr 22, 2025

Apr 20, 2025

Geode Capital Management LLC Acquires 12,510 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 20, 2025

Apr 18, 2025

Can you now get a good deal on Enliven Therapeutics Inc’s shares? - uspostnews.com

Apr 18, 2025

Apr 15, 2025

(ELVN) Trading Report - news.stocktradersdaily.com

Apr 15, 2025

Apr 13, 2025

Vanguard Group Inc. Purchases 55,283 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 13, 2025

Apr 13, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Boosted by Wellington Management Group LLP - Defense World

Apr 13, 2025

Apr 11, 2025

KLP Kapitalforvaltning AS Makes New $97,000 Investment in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 11, 2025

Apr 10, 2025

Ratios Revealed: Decoding Enliven Therapeutics Inc (ELVN)’s Financial Health - DWinneX

Apr 10, 2025

Apr 10, 2025

Corebridge Financial Inc. Trims Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 10, 2025

Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 By Investing.com - Investing.com India

Apr 09, 2025

Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 - Investing.com Australia

Apr 09, 2025

Apr 06, 2025

Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High? - MSN

Apr 06, 2025

Apr 02, 2025

Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting - StreetInsider

Apr 02, 2025

Apr 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 4.9% After Insider Selling - Defense World

Apr 02, 2025

Apr 01, 2025

Enliven Therapeutics CFO Benjamin Hohl sells $69,320 in stock By Investing.com - Investing.com UK

Apr 01, 2025

Mar 31, 2025

Enliven Therapeutics CFO Benjamin Hohl sells $69,320 in stock - Investing.com

Mar 31, 2025

Mar 30, 2025

Where are the Opportunities in (ELVN) - news.stocktradersdaily.com

Mar 30, 2025

Mar 30, 2025

Swiss National Bank Increases Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 30, 2025

Mar 27, 2025

Enliven Therapeutics CFO sells $22,504 in stock By Investing.com - Investing.com Nigeria

Mar 27, 2025

Mar 26, 2025

Enliven Therapeutics CFO sells $22,504 in stock - Investing.com India

Mar 26, 2025

Mar 25, 2025

Charles Schwab Investment Management Inc. Grows Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 25, 2025

Mar 23, 2025

HC Wainwright Forecasts Strong Price Appreciation for Enliven Therapeutics (NASDAQ:ELVN) Stock - Defense World

Mar 23, 2025

Mar 22, 2025

Bank of New York Mellon Corp Sells 828 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 22, 2025

Mar 21, 2025

Enliven Therapeutics chief scientific officer sells $257,575 in stock By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Enliven Therapeutics chief scientific officer sells $257,575 in stock - Investing.com India

Mar 21, 2025

Mar 20, 2025

Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

(ELVN) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 20, 2025

Mar 20, 2025

Lifesci Capital Issues Optimistic Forecast for ELVN Earnings - Defense World

Mar 20, 2025

Mar 19, 2025

Enliven Therapeutics CEO Samuel Kintz sells $260,320 in stock - Investing.com

Mar 19, 2025

Mar 19, 2025

Enliven Therapeutics CEO Samuel Kintz sells $260,320 in stock By Investing.com - Investing.com UK

Mar 19, 2025

Mar 15, 2025

Decoding Enliven Therapeutics Inc (ELVN): A Strategic SWOT Insig - GuruFocus.com

Mar 15, 2025

Mar 14, 2025

Enliven grew fourth-quarter R&D spending with trials underway - BizWest

Mar 14, 2025

Mar 14, 2025

Enliven Therapeutics Stock (ELVN): Promising Advances in Oncology Pipeline - Value The Markets

Mar 14, 2025

Mar 14, 2025

Enliven Therapeutics Reports 2024 Financial Results - TipRanks

Mar 14, 2025

Mar 13, 2025

Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - Citizentribune

Mar 13, 2025

Mar 13, 2025

Enliven Therapeutics Inc. (ELVN) reports earnings - Quartz

Mar 13, 2025

Mar 13, 2025

Enliven Therapeutics Q4 Operating Expenses USD 26.896 Million -March 13, 2025 at 05:37 pm EDT - Marketscreener.com

Mar 13, 2025